Recent studies have shown that GLP-1 use is associated with a reduction in cases of dementia among people with type 2 diabetes (something that's likely to also be true in a broader population of people at risk for dementia)
However, as our understanding of cellular signaling has deepened, two compounds have emerged as the primary contenders for modern recovery: BPC-157 and TB-500
Community discussion of KLOW most often centers on tissue-repair research, skin/connective-tissue remodeling, recovery research, and anti-inflammatory research
Major dietary sources include animal products like meat, seafood, eggs, nuts, and dairy products (including low-fat dairy)
Notably, research by Teichman et al
Both have a long history of use as dietary supplements